6 Revvity Insiders Execute Stock Options Worth $3.5M in Coordinated Move
Six Revvity Inc. (NYSE: RVTY) executives executed a coordinated series of stock transactions between February 4 and February 17, 2026, exercising options worth approximately $3.5 million and managing tax obligations through share withholdings, according to recent SEC Form 4 filings.
The Trades
The insider activity centered around two distinct transaction types: option exercises with subsequent sales, and tax-related share withholdings. CEO Prahlad R. Singh led the group with the largest transaction, exercising 25,525 shares at $92.09 per share on February 5, representing a total exercise value of $2,350,597. Singh immediately sold 1,307 shares following the exercise.
Chief Financial Officer Joel S. Goldberg followed with a similar pattern, exercising 12,717 shares at the same $92.09 strike price for a total of $1,171,108, then selling 6,424 shares. Combined, these two executives alone accounted for over $3.5 million in option exercises.
The remaining four executives—Victor Miriame, Tajinder S. Vohra, Anita Gonzales, and Maxwell Krakowiak—participated primarily through tax withholding transactions on February 17 at $96.03 per share. All six executives also received equity awards on February 4 at no cost, suggesting this was part of a scheduled compensation event.
Who's Trading
The insider group represents Revvity's senior leadership team, with CEO Singh and CFO Goldberg executing the most substantial transactions. The timing and structure of these trades appear coordinated, with all executives receiving awards on the same date and conducting tax withholdings within the same window.
Singh's $2.35 million option exercise stands out as the largest single transaction in the cluster. His decision to sell only 1,307 shares while exercising 25,525 suggests retention of significant equity exposure. Goldberg's higher sale ratio—selling 6,424 of 12,717 exercised shares—indicates a different approach to managing his position.
The four other executives' transactions were limited to tax-related withholdings, a common practice where companies withhold shares to cover tax obligations on vesting equity. These transactions occurred at $96.03 on February 17, representing a 4.3% premium to the $92.09 exercise price used by Singh and Goldberg.
What to Watch
This cluster of insider activity suggests several key points for investors to monitor. First, the coordinated timing around February 4 indicates this was likely a scheduled vesting or grant date rather than opportunistic trading. The fact that executives exercised options at $92.09 when the stock later traded at $96.03 and $101.13 suggests confidence in the share price stability.
The variation in sale patterns is notable. While Singh retained the vast majority of his exercised shares, Goldberg sold approximately half. This difference in retention strategies among top executives may reflect varying personal financial planning needs rather than divergent views on company prospects.
The presence of multiple tax withholding transactions at consistent prices indicates standard equity compensation practices at Revvity. These automatic withholdings to cover tax obligations are typically non-discretionary and shouldn't be interpreted as bearish signals.
For context, Revvity operates in the life sciences and diagnostics sectors, providing critical tools and services for drug discovery and development. The company's stock performance and insider trading patterns often reflect broader trends in biotech investment and pharmaceutical R&D spending.
Investors should note that while this cluster represents significant dollar amounts, the transactions appear to be primarily related to standard equity compensation practices rather than speculative trading. The retention of substantial shares by the CEO following his option exercise may be viewed as a positive signal regarding management's confidence in the company's trajectory.
The timing of these transactions in mid-February 2026 may also correlate with the company's fiscal calendar and earnings announcements. Investors should monitor upcoming quarterly results and guidance updates for additional context on why insiders chose this window for their equity transactions.
*Source: SEC Form 4 filings dated February 4-17, 2026*
*StockCliff Research*